About Shark Cartilage
Dried shark cartilage, a source of chondroitin-type glycosaminoglycans. Historically marketed for cancer (angiogenesis inhibition) and joints; controlled trials of shark-cartilage products (including AE-941/Neovastat) failed to show anticancer benefit, and joint evidence is weak. Sustainability and heavy-metal contamination concerns apply.
What Shark Cartilage supports
- Contains chondroitin-type compounds — joint benefit is unproven and cancer claims were refuted by RCTs.
Clinical evidence
Limited clinical evidence. Controlled trials (Neovastat/AE-941) negative for cancer; no solid joint efficacy.
Reference